\begin{tblr}{
 column{1} = {l},
 column{2,3} = {c},
 hline{1,19} = {-}{0.08em},
 hline{2} = {-}{0.05em},
}
Analysis/Comparison & Peptide & $-\log_{10}(\text{adjusted p-value})$ \\
 $\text{ME/CFS}_\text{all}$ vs. $\text{Healthy controls}$ & EBNA6\_0066 & 0.743 \\
 & BLRF2\_0005 & 0.486 \\
 & EBNA4\_0392 & 0.486 \\
 & EBNA4\_0497 & 0.486 \\
 & EBNA4\_0529 & 0.486 \\
 & & \\
% 
 $\text{ME/CFS}_\text{inf}$ vs. $\text{Healthy controls}$ & EBNA6\_0066 & 2.693 \\
 & EBNA6\_0070 & 2.693 \\
 & EBNA4\_0529 & 1.794 \\
 & EBNA3\_0380 & 1.270 \\
 & EBNA6\_0569 & 1.270 \\
 & & \\
% 
 $\text{ME/CFS}_\text{noinf}$ vs. $\text{Healthy controls}$ & EBNA6\_0782 & 1.193 \\
 & BALF2\_0358 & 1.153 \\
 & BALF2\_0765 & 1.153 \\
 & BALF5\_0041 & 1.153 \\
 & BALF5\_0206 & 1.153 \\
\end{tblr}
